BIOMAT Database Logo BIOMAT Database Logo

[Chemotherapy of ovarian tumors using cis-platin]. 1987

L Laurová, and J Kobilková, and J Novotná, and K Motlík, and M Fricová, and J Hornický

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

L Laurová, and J Kobilková, and J Novotná, and K Motlík, and M Fricová, and J Hornický
Cis-platin-Mecy as salvage chemotherapy in recurrent advanced ovarian carcinoma.
January 1989, Giornale italiano di oncologia,
L Laurová, and J Kobilková, and J Novotná, and K Motlík, and M Fricová, and J Hornický
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines.
September 2011, Journal of ovarian research,
L Laurová, and J Kobilková, and J Novotná, and K Motlík, and M Fricová, and J Hornický
[Brain metastasis of ovarian cancer treated by chemotherapy including cis-platin: a case report].
February 1989, No shinkei geka. Neurological surgery,
L Laurová, and J Kobilková, and J Novotná, and K Motlík, and M Fricová, and J Hornický
[Intermittent administration of the combination chemotherapy with cis-platin, adriamycin and cyclophosphamide (cyclic-PAC chemotherapy) for the ovarian cancers].
April 1990, Nihon Sanka Fujinka Gakkai zasshi,
L Laurová, and J Kobilková, and J Novotná, and K Motlík, and M Fricová, and J Hornický
[Chemotherapy of nonseminomatous testicular tumors. The results of a pilot study with reduced cis-platin dosage].
June 1983, Onkologie,
L Laurová, and J Kobilková, and J Novotná, and K Motlík, and M Fricová, and J Hornický
[Combined chemotherapy with 5-FU+cis-platin or UFT+cisplatin].
July 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
L Laurová, and J Kobilková, and J Novotná, and K Motlík, and M Fricová, and J Hornický
Cis-platin induced anaemia.
February 1987, The New Zealand medical journal,
L Laurová, and J Kobilková, and J Novotná, and K Motlík, and M Fricová, and J Hornický
Testicular function following combination chemotherapy with cis-platin, vinblastine, and bleomycin.
January 1984, Medical and pediatric oncology,
L Laurová, and J Kobilková, and J Novotná, and K Motlík, and M Fricová, and J Hornický
Randomized trial of the addition of cis-platin (DDP) and/or BCG to cyclophosphamide (CTX) chemotherapy for ovarian carcinoma.
March 1987, Journal of surgical oncology,
L Laurová, and J Kobilková, and J Novotná, and K Motlík, and M Fricová, and J Hornický
Tetany associated with cis-platin.
December 1980, Lancet (London, England),
Copied contents to your clipboard!